Skip to Content
  • Previous Rank14
  • Revenues ($M)130,474
  • Revenue Percent Change6.5%
  • Profits ($M)5,619
  • Profits Percent Change-0.1%
  • Market Value (as of March 31, 2015)112,813

UnitedHealth Group serves more than 85 million patients worldwide with its health benefits and services and is the largest U.S. health insurer, surpassing the likes of Kaiser Foundation Group and Anthem. Their businesses don’t stop there. CEO Stephen Hemsley has been investing heavily in Optum, its health services arm that includes a pharmacy benefits manager (PBM) and health data analytics. While Optum represents only a third of the Minnesota-based company’s total revenues, the unit is growing fast. To bolster Optum’s pharmacy business, UnitedHealth acquired Catamaran for $12.8 billion in March, which more than doubled its PBM members to 65 million. The additional scale gives UnitedHealth more sway when it comes to negotiating drug prices with manufacturers. While drug spending has been relatively stable in recent years as generics replaced blockbuster drugs, the rise of specialty drugs for diseases like high cholesterol and hepatitis C has put increased pressure on PMBs to help employers rein in costs. Drug discounts are also beneficial for PMBs, including UnitedHealth, which keep a portion of the discounts they obtain from drug makers—sometimes as much as 15% of the negotiated rebates.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

Stephen J. Hemsley
Health Care: Insurance and Managed Care
Health Care
HQ Location
Minnetonka, MN
Years on List21

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)130,4746.5%
Profits ($M)5,619-0.1%
Total Stockholder Equity32,454-
Market Value (as of March 31, 2015)112,813-

Profit Ratios

Profit as % of Revenues4.3%
Profits as % of Assets6.5%
Profits as % of Stockholder Equity17.3%

Earnings Per Share (last fiscal year)

Earnings Per Share ($)5.7
EPS % Change (from 2013)3.6%
EPS % Change (5 year annual rate)12%
EPS % Change (10 year annual rate)11.2%

Total Return

Total Return to Investors (2014)36.4%
Total Return to Investors (5 year, annualized)28.9%
Total Return to Investors (10 year, annualized)9.5%